Free Trial

Medifast (MED) Competitors

Medifast logo
$14.47 -0.21 (-1.43%)
Closing price 07/11/2025 03:58 PM Eastern
Extended Trading
$14.42 -0.05 (-0.35%)
As of 07/11/2025 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MED vs. LW, NOMD, USNA, NUS, NATR, VERU, EL, IPAR, PBH, and HLF

Should you be buying Medifast stock or one of its competitors? The main competitors of Medifast include Lamb Weston (LW), Nomad Foods (NOMD), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Veru (VERU), Estee Lauder Companies (EL), Interparfums (IPAR), Prestige Consumer Healthcare (PBH), and Herbalife (HLF).

Medifast vs. Its Competitors

MEDIFAST (NYSE:MED) and Lamb Weston (NYSE:LW) are both consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

In the previous week, Lamb Weston had 20 more articles in the media than MEDIFAST. MarketBeat recorded 22 mentions for Lamb Weston and 2 mentions for MEDIFAST. Lamb Weston's average media sentiment score of 0.91 beat MEDIFAST's score of 0.76 indicating that Lamb Weston is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MEDIFAST
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Lamb Weston
12 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

MEDIFAST has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, Lamb Weston has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500.

MEDIFAST currently has a consensus price target of $16.50, suggesting a potential upside of 14.03%. Lamb Weston has a consensus price target of $67.64, suggesting a potential upside of 31.84%. Given Lamb Weston's stronger consensus rating and higher possible upside, analysts clearly believe Lamb Weston is more favorable than MEDIFAST.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MEDIFAST
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Lamb Weston
0 Sell rating(s)
8 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33

Lamb Weston has higher revenue and earnings than MEDIFAST. MEDIFAST is trading at a lower price-to-earnings ratio than Lamb Weston, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MEDIFAST$602.46M0.26$2.09M-$0.65-22.26
Lamb Weston$6.47B1.12$725.50M$2.5520.12

Lamb Weston has a net margin of 5.74% compared to MEDIFAST's net margin of -1.29%. Lamb Weston's return on equity of 27.25% beat MEDIFAST's return on equity.

Company Net Margins Return on Equity Return on Assets
MEDIFAST-1.29% 6.63% 4.81%
Lamb Weston 5.74%27.25%6.31%

95.5% of MEDIFAST shares are owned by institutional investors. Comparatively, 89.6% of Lamb Weston shares are owned by institutional investors. 2.9% of MEDIFAST shares are owned by insiders. Comparatively, 0.7% of Lamb Weston shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Lamb Weston beats MEDIFAST on 13 of the 16 factors compared between the two stocks.

Get Medifast News Delivered to You Automatically

Sign up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MED vs. The Competition

MetricMEDIFASTFOOD IndustryStaples SectorNYSE Exchange
Market Cap$158.27M$8.35B$16.22B$20.66B
Dividend YieldN/A3.47%3.11%3.72%
P/E Ratio-22.2622.7116.6026.54
Price / Sales0.261.7346.1742.50
Price / Cash4.9012.6414.7022.32
Price / Book0.753.556.094.57
Net Income$2.09M$398.24M$680.31M$989.30M
7 Day Performance-0.75%4.35%2.08%0.20%
1 Month Performance9.95%0.87%1.61%3.95%
1 Year Performance-23.20%-1.60%4.79%10.27%

Medifast Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MED
Medifast
3.4763 of 5 stars
$14.47
-1.4%
$16.50
+14.0%
-24.6%$158.27M$602.46M-22.26870
LW
Lamb Weston
4.7234 of 5 stars
$51.94
-2.7%
$67.73
+30.4%
-35.0%$7.33B$6.47B20.3710,700Analyst Forecast
Options Volume
NOMD
Nomad Foods
4.5141 of 5 stars
$16.98
-0.4%
$24.00
+41.3%
+5.3%$2.60B$3.35B11.327,788News Coverage
Positive News
USNA
USANA Health Sciences
3.8603 of 5 stars
$30.58
-1.8%
$36.00
+17.7%
-26.3%$569.40M$854.50M16.801,700
NUS
Nu Skin Enterprises
2.9889 of 5 stars
$8.00
-1.1%
$6.88
-14.1%
-11.5%$395.28M$1.73B-10.003,100
NATR
Nature's Sunshine Products
1.7165 of 5 stars
$14.79
+2.0%
$18.33
+24.0%
+3.9%$273.02M$454.36M27.91850Positive News
High Trading Volume
VERU
Veru
2.9 of 5 stars
$0.58
+0.1%
$4.00
+587.5%
-35.5%$85.28M$16.89M-2.42230Positive News
Gap Up
EL
Estee Lauder Companies
4.1216 of 5 stars
$80.84
+0.9%
$74.45
-7.9%
-10.3%$29.08B$14.79B-33.4063,000Positive News
Analyst Forecast
IPAR
Interparfums
3.9164 of 5 stars
$131.31
-0.5%
$157.60
+20.0%
+11.3%$4.22B$1.45B25.55530Positive News
PBH
Prestige Consumer Healthcare
3.8472 of 5 stars
$79.84
-1.3%
$93.33
+16.9%
+8.7%$3.95B$1.14B18.61540Positive News
HLF
Herbalife
4.2631 of 5 stars
$8.59
-1.6%
$11.50
+33.9%
-4.1%$874.89M$4.99B3.148,600

Related Companies and Tools


This page (NYSE:MED) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners